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Murine Vaginal Colonization Model for Investigating Asymptomatic
Mucosal Carriage of Streptococcus pyogenes
Michael E. Watson, Jr.,a Hailyn V. Nielsen,b Scott J. Hultgren,b,c Michael G. Caparonb,c
Divison of Pediatric Infectious Diseases, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USAa; Department of Molecular
Microbiology, Washington University Medical School, St. Louis, Missouri, USAb; Center for Women’s Infectious Disease Research, Washington University School of
Medicine, St. Louis, Missouri, USAc
While many virulence factors promoting Streptococcus pyogenes invasive disease have been described, specific streptococcal fac-
tors and host properties influencing asymptomatic mucosal carriage remain uncertain. To address the need for a refinedmodel
of prolonged S. pyogenes asymptomatic mucosal colonization, we have adapted a preestrogenized murine vaginal colonization
model for S. pyogenes. In this model, derivatives of strains HSC5, SF370, JRS4, NZ131, andMEW123 established a reproducible,
asymptomatic colonization of the vaginal mucosa over a period of typically 3 to 4 weeks’ duration at a relatively high coloniza-
tion efficiency. Prior treatment with estradiol prolonged streptococcal colonization and was associated with reduced inflamma-
tion in the colonized vaginal epithelium as well as a decreased leukocyte presence in vaginal fluid compared to the levels of in-
flammation and leukocyte presence in non-estradiol-treated control mice. The utility of our model for investigating S. pyogenes
factors contributing to mucosal carriage was verified, as a mutant with a mutation in the transcriptional regulator catabolite
control protein A (CcpA) demonstrated significant impairment in vaginal colonization. An assessment of in vivo transcriptional
activity in the CcpA strain for several known CcpA-regulated genes identified significantly elevated transcription of lactate oxi-
dase (lctO) correlating with excessive generation of hydrogen peroxide to self-lethal levels. Deletion of lctO did not impair colo-
nization, but deletion of lctO in a CcpA strain prolonged carriage, exceeding even that of the wild-type strain. Thus, while LctO
is not essential for vaginal colonization, its dysregulation is deleterious, highlighting the critical role of CcpA in promoting mu-
cosal colonization. The vaginal colonization model should prove effective for future analyses of S. pyogenesmucosal
colonization.
TheGram-positive pathogen Streptococcus pyogenes, or group Astreptococcus, is responsible for a wide variety of clinicalman-
ifestations ranging from the relatively benign and superficial otitis
media, impetigo, and pharyngitis to less common andmore inva-
sive conditions, including necrotizing fasciitis and toxic shock
syndrome, in addition to the postinfectious complications rheu-
matic fever and glomerulonephritis (1). The ability to produce
such a diversity of infections in so many different tissue compart-
ments is testament to the extensive plasticity of the S. pyogenes
transcriptome and an abundance of secreted virulence factors (2).
While not considered normal human flora, S. pyogenes can be
identified as a colonizer of mucosal surfaces of the oropharynx,
rectum, and vaginal mucosa, and a prolonged asymptomatic car-
riage state can develop (3–7). How S. pyogenes carriage exists on a
mucosal surface without inducing disease is poorly understood,
but the issue is significant in terms of gaining an improved under-
standing of host-pathogen interactions and the regulation of mu-
cosal immunity. Furthermore, asymptomatic oropharyngeal car-
riage of S. pyogenes continues to confound the results of clinical
testing for those with symptoms of pharyngitis, frequently, chil-
dren with viral infections, in which the detection of carrier strains
mistakenly results in inappropriate antibiotic exposures and ex-
penses (8, 9).
Modeling of asymptomatic mucosal carriage in the human-
restricted organism S. pyogenes has been challenging. Although
murine and primate models of S. pyogenes oropharyngeal and na-
sopharyngeal colonization exist, their utility has several limita-
tions, including limited access to the pharyngeal tissue site, the
high cost andmaintenance requirements of a primate colony, and
the fact that many of these models are not capable of supporting
more than a few specific strains of S. pyogenes for a limited period
of time at a relatively low efficiency of colonization (10, 11). To
overcome several of these obstacles, we have taken a novel ap-
proach by adapting a murine vaginal epithelial model to investi-
gate S. pyogenes colonization and prolonged carriage.
Murine vaginal colonization models in preestrogenized mice
have previously been used to investigate the mucosal biology of
human pathogens, including Candida albicans (12), Trichomonas
vaginalis (13), group B streptococcus (14), and Neisseria gonor-
rhoeae (15). The anatomy and physiology of the murine vaginal
mucosa are quite similar to those of the human vaginal mucosa,
and both respond similarly to estrogen cycling, with thickening
and proliferation of the epithelial surface and accumulation of
glycogen in the intermediate and superficial layers, although to a
lesser degree in mice than in humans (16). While mice have a 10-
to 25-fold lower level of serum estrogen, they respond dramati-
cally to exogenous estradiol treatment, with enhanced glycogen
deposition, intense epithelial proliferation, and increased epithe-
Received 9 January 2013 Returned for modification 16 February 2013
Accepted 21 February 2013
Published ahead of print 4 March 2013
Editor: A. Camilli
Address correspondence to Michael G. Caparon, caparon@borcim.wustl.edu.
Supplemental material for this article may be found at http://dx.doi.org/10.1128
/IAI.00021-13.
Copyright © 2013, American Society for Microbiology. All Rights Reserved.
doi:10.1128/IAI.00021-13




arch 31, 2014 by W







lial cell thickness, which overall presents a more human-like vag-
inal profile (17, 18). In addition, human and murine vaginal se-
cretions have similar compositions, with similar concentrations of
glucose (3.3 mM and 4.4 mM, respectively) and lactate (6.2 mM
and 8.4 mM, respectively) (19).
Asymptomatic human vaginal carriage of S. pyogenes is typi-
cally detected at a low frequency among women of reproductive
age, about 0.03% to 1% (3, 20). Group A streptococcus can be
isolated from vaginal swab specimen cultures at a greater fre-
quency from cases of vulvovaginitis and puerperal sepsis, often
occurring with prior or concurrent pharyngitis (21–24). In partic-
ular, S. pyogenes serotypeM28 isolates are overrepresented in cases
of human female urogenital tract infection, puerperal sepsis, and
neonatal infections (25–27). All M28 isolates and isolates of other
serotypes associated with puerperal infections exhibit carriage of a
37.4-kb genomic island designated region of difference 2 (RD2),
which is shared with group B streptococcus and which contains 7
putative proteins and potential virulence factors (28, 29). Hence,
investigation of S. pyogenes vaginal colonization and invasive in-
fections represents an opportunity to gain greater insight into bac-
terial pathogenesis, particularly with regard to interactions with
the host mucosal immunity.
The regulation of metabolism and virulence factor expression
among carriage isolates is an active field of investigation. Global
regulators of bacterial gene transcription sensitive to environmen-
tal cues are increasingly recognized for their importance in patho-
genesis (for a review, see references 30 and 31). Environmental
carbohydrate concentrations have been determined to be a major
environmental cue for S. pyogenes that is directly coupled to tran-
scriptional regulation through the process of carbon catabolite
repression (CCR) and themajor CCR regulator catabolite control
protein A (CcpA) (32–35). CcpA is a member of the LacI/GalR
family of activator/repressor transcription factors and is widely
conserved among low-GC-content Gram-positive prokaryotes,
including S. pyogenes. A detailed discussion of the biochemistry of
CcpA-dependent CCR is beyond the scope of this article but has
been discussed elsewhere (36). In short, the accumulation of gly-
colytic intermediates, including fructose-1,6-bisphosphate, from
metabolism in a carbohydrate-rich environment results in a signal
cascade activating CcpA. CcpA influences transcriptional expres-
sion by binding to operator sequences termed catabolite-respon-
sive elements (cre), usually adjacent to or within promoter se-
quences of open reading frames regulated byCcpA, and regulating
access of the RNA polymerase complex (36). Within S. pyogenes,
carbon catabolite repression is central to global transcriptional
regulation, not only by regulating carbohydratemetabolism path-
ways but also by functioning as a transcriptional activator or re-
pressor of several important virulence factors, including the cys-
teine protease SpeB, the cytolysin streptolysin S, hyaluronic acid
capsule, the extracellular DNase Spd, and the immunoglobulin-
degrading EndoS (32–34, 37). Given the central role of CcpA in
transcriptional regulation, it follows that loss of CcpA activity
would be associated with dysregulation of gene expression at a
detriment to pathogenesis. Supporting evidence is that S. pyogenes
CcpA strains have been demonstrated to have reduced virulence
in the murine skin ulcer model (34), reduced virulence in a mu-
rine intraperitonealmodel of invasive infection, and impaired col-
onization in the murine oropharynx (32). While the mechanism
of attenuated virulence in the CcpA strains has not been deter-
mined, we would hypothesize that the loss of CcpA-dependent
transcriptional regulation contributes to a loss of virulence
through dysregulation of gene expression, with an inappropriate
timing and/or magnitude of gene transcription impairing fitness.
In this study, we have adapted a preestrogenized murine vagi-
nal mucosa model to investigate S. pyogenes colonization and car-
riage. We report that several S. pyogenes strains from diverse clin-
ical backgrounds are capable of prolonged carriage at a relatively
high degree of colonization efficiency. Estrogenization of mice
was shown to promote a sustained and asymptomatic vaginal col-
onization analogous to that found in women of reproductive age
with normal estrogen levels (3, 22, 23). Furthermore, we have
validated the utility of our model for investigating streptococcal
factors, in demonstrating that the absence of CcpA inhibits pro-
longed murine vaginal carriage through dysregulation of gene ex-
pression, including increased lactate oxidase (LctO) expression in
vivo, likely limiting mucosal survival. This report adds a novel
animal model to the field of S. pyogenes colonization and carriage
and further contributes to our understanding of the role of global
transcriptional regulators and their role in the biology of mucosal
pathogens.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. The principal strain
used in this study was S. pyogenes HSC12, a spontaneous streptomycin-
resistant derivative of the M14 strain HSC5 (38). Whole-genome se-
quencing has revealed that HSC12 contains a single nucleotide polymor-
phism at nucleotide position 1960 (AAA to ACA) in the 30S ribosomal
subunit S12p (rpsL; SPy_0271) resulting in a missense mutation (K56T)
conferring high-level streptomycin resistance (M. E. Watson, Jr., G. C.
Port, andM. C. Caparon, unpublished data). Other strains used are listed
in Table 1. Unless otherwise stated, all S. pyogenes strains had equivalent
growth rates and yields in the media tested (data not shown). Routine
culture of S. pyogenes was performed in Todd-Hewitt medium (Becton,
Dickinson, Franklin Lakes, NJ) supplemented with 0.2% (wt/vol) yeast
extract (Difco Laboratories, Detroit, MI) (THY medium). Where re-
quired, Bacto agar (Difco) was added to a final concentration of 1.4%
(wt/vol) to produce solidmedium. Experiments that required low glucose
concentrations were performed in C medium (41). Incubation was per-
formed at 37°C under anaerobic conditions (GasPak; Becton, Dickinson)
for solid medium or in sealed tubes without agitation for liquid medium.
Aerobic culture was conducted as described previously (33). For inocula-
tion of mice, S. pyogeneswas harvested from culture in THY broth at early
logarithmic phase (optical density at 600 nm [OD600], 0.2), washed once
in phosphate-buffered saline (PBS), briefly sonicated on ice to disrupt
long streptococcal chains, and resuspended in PBS to 108 CFU/ml. For
cloning of recombinant DNA, Escherichia coli strain DH5 or TOP10
(Invitrogen, Grand Island, NY) was cultured in Luria-Bertani (LB) broth.
When appropriate, antibiotics were added at the following concentra-
tions: erythromycin, 500 g/ml for E. coli and 1 g/ml for S. pyogenes;
spectinomycin,100g/ml for both E. coli and S. pyogenes; and streptomy-
cin, 1,000 g/ml for S. pyogenes (all were obtained from Sigma Chemical
Co., St. Louis, MO).
DNAmanipulation and strain construction. Plasmid DNA was iso-
lated by standardmethods and used to transform S. pyogenes as previously
described (42). Restriction endonucleases, ligases, and polymerases were
used according to the manufacturer’s recommendations (New England
BioLabs, Ipswich, MA). The fidelity of all constructs derived by PCR was
confirmed by DNA sequencing analysis performed by a commercial ven-
dor (Integrated DNA Technologies, Inc., Coralville, IA). All references to
genomic loci are based on the genome of S. pyogenes strain SF370 (43).
In-frame deletion mutations were constructed using a routine method of
allelic exchange (44) via S. pyogenes transformation by electroporation
with derivatives of the E. coli-to-streptococcus temperature-sensitive
shuttle vector pJRS233, previously reported as pCK195 for ccpA
S. pyogenes Vaginal Mucosa Carriage Model
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(SPy_0514) and pCK37 for lctO (SPy_0414) (33). Generation of sponta-
neous streptomycin-resistant isolates was performed by plating a high
density of S. pyogenes onto THY agar plates supplemented with 1 mg/ml
streptomycin and incubation at 37°C overnight; streptomycin-resistant
clones occurred in approximately 1 of 109 CFU plated. All mutants were
confirmed by PCR, DNA sequencing, and phenotypic assays, when avail-
able. Descriptions of the resulting strains are listed in Table 1.
Reversion of the CcpA strain to CcpAr. Although several plasmid
systems for S. pyogenes exist, none proved suitable for long-term in vivo
stability in the absence of selective antibiotic pressure. Therefore, to re-
verse the ccpA in-frame deletionmutation, a strategy was implemented to
restore thewild-type (WT) locus in theCcpAmutant. A 2.2-kb fragment
containing the entire ccpA open reading frame and flanking regions was
amplified from HSC12 genomic DNA using primers CK214 (5=-CCCAT
CGATGAGCGATGACGTCTGTTTCGGTAG-3=) andCK217 (5=-CCCG
GATCCGGATCTGCTCCGTACTGCTCC-3=) (33), which were digested
with ClaI and BamHI, respectively (sequences underlined in the primers),
and inserted between the same sites of pJRS233 (44). The resulting plas-
mid (pMEW74) was then used to restore the wild-type ccpA locus as
described above, creating strain MEW106 with restored CcpA (CcpAr)
(Table 1).
Murine vaginal colonization model. C57BL/6J and BALB/c mice
were obtained from The Jackson Laboratory (Bar Harbor, ME) and were
allowed to acclimatize for 1 week prior to manipulations. All mice were
female and unless otherwise specified were used at 7 to 8 weeks of age. To
synchronize estral cycles, mice were estrogenized by intraperitoneal injec-
tion of up to 0.5 mg -estradiol 17-valerate (Sigma) dissolved in 0.1 ml
sterile sesame oil (Sigma) 2 days prior to streptococcal inoculation and
again on the day of inoculation (day 0). In some experiments, mice re-
ceived intraperitoneal injections of 0.1 ml sterile sesame oil as a vector-
only control; these mice are referred to as mock treated throughout this
article. On day 0, mice were sedated by brief inhalation of 80% carbon
dioxide–20% oxygen gas, and the various inocula of S. pyogenes described
in the text were instilled into the vaginal vault using a P20 micropipette
(Gilson, Inc., Middleton, WI) in a total volume of 20 l PBS. In some
experiments, control mice received a vaginal instillation of phosphate-
buffered saline alone; these mice are referred to as uncolonized through-
out this article. At successive intervals over a 1-month period postinocu-
lation, the vaginal vaults of sedated mice were gently washed with 50 l
PBS and serial dilutions in PBSwere plated onto THY agar plates contain-
ing 1,000 g/ml streptomycin to determine the numbers of viable CFU.
This concentration of streptomycin suppressed the growth of the normal
mouse vaginal flora but had no effect on the growth of the streptomycin-
resistant S. pyogenes strains. The detection limit was mathematically cal-
culated as theCFUdensity belowwhich our drop-platingmethodmaynot
detect the growth of viable streptococci. The drop-plating method in-
volves making 10-fold serial dilutions of the vaginal wash specimens in
phosphate-buffered saline and spotting 6-l aliquots of the dilutions and
an undiluted neat specimen onto agar plates in duplicate. The average
number of colonies counted between duplicate spots from 6 l was then
adjusted for the dilution factor to calculate the number of CFU/ml or the
number of CFU per 50-l vaginal wash. The fewest number of colonies
that could be identified was 1 colony between 2 duplicate spots, and when
this average number (0.5) was adjusted for the dilution factor and plating
volume (6 l), the resulting number was approximately 84 CFU/ml. For
colonization experiments, between 5 and 20 mice were tested per S. pyo-
genes strain, as indicated in the relevant figure legends. This experimental
protocol (20100186) was approved by the Animal Studies Committee of
the Washington University School of Medicine.
Determination of leukocyte density in vaginal wash specimens.Ali-
quots of vaginal wash specimens (20 l) were spotted onto glass micro-
scope slides (Fisher Scientific, Pittsburg, PA) without dilution and al-
lowed to air dry. Specimens were heat fixed and then stained using a
commercially available, modified Wright-Giemsa stain (Kwik-Diff;
TABLE 1 Bacterial strains and plasmids
Strain or plasmid Description (M type or phenotype) Reference or source
Strains
S. pyogenes
JRS4 Spontaneous streptomycin-resistant derivative of strain D471 (M6) 50
SF370 Invasive isolate from wound infection (M1) 43
HSC12 Spontaneous streptomycin-resistant derivative of strain HSC5 rpsLK56T
c (M14) 38
MEW16 HSC12 with a lctO in-frame deletion produced by allelic exchange with pCK37 (LctO) This study
MEW29 Spontaneous streptomycin-resistant derivative of strain SF370 This study
MEW41 HSC12 with a ccpA in-frame deletion produced using plasmid pCK195 (CcpA)a This study
MEW47 MEW41 with a lctO in-frame deletion produced by using plasmid pCK37 (CcpA LctO)a This study
MEW106 MEW41 with full-length ccpA produced using plasmid pMEW74,a WT revertant (CcpAr) This study
MEW123 Streptomycin-resistant derivative of pediatric pharyngitis isolate (M28) produced by allelic
exchange with pMEW96
This study
MEW132 Spontaneous streptomycin-resistant derivative of strain NZ131 from glomerulonephritis (M49) J. Changb




pJRS233 6.0-kb E. coli-streptococcal temperature-restrictive shuttle vector for allelic exchange,
erythromycin resistance marker
44
pCK37 pJRS233 with a lctO in-frame deletion allele 33
pCK195 pJRS233 with a ccpA in-frame deletion allele 33
pMEW74 pJRS233 with a ccpA full-length open reading frame for complementation This study
pMEW96 pJRS233 with an rpsL point mutation allele (K56T) conferring streptomycin resistance after
allelic exchange
This study
a The plasmid listed was used to replace the wild-type allele in the genome by a standard method (44).
b Original NZ131 streptomycin-resistant isolate derived by Jennifer Chang and Michael Federle (University of Illinois—Chicago).
c rpsLK56T, the K-to-T change at position 56 encoded by rpsL.
Watson et al.
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Thermo Fisher Scientific, Waltham, MA). Stained slides were examined
under a bright-field microscope at 	10 to 	40 magnification using a
Leica DM100 microscope (Leica Microsystems Inc., Buffalo Grove, IL),
and the proportions of nucleated epithelial cells, anucleated cornified ep-
ithelial cells, and leukocytes were determined (40). Data presented are the
means and standard errors of the means derived from at least 3 indepen-
dent experiments, where each individual experimental point was analyzed
by assessment of vaginal wash specimens from at least 3 mice per group.
For each assessment of leukocyte density, multiple fields of view were
examined.
Histologic examination of mouse vaginal tissue. In selected experi-
ments mice were euthanized and the vaginal canal was removed and bi-
sected longitudinally for analysis as follows: one half of the vagina was
immediately placed into 4% paraformaldehyde in PBS for fixation, and
the other half was immediately homogenized for recovery of whole-tissue
numbers of CFU or RNA (see below). Following overnight fixation, the
tissues were placed in ethanol and then encased in paraffin, sectioned, and
stained with Gram stain, hematoxylin-eosin, and periodic acid-Schiff
(PAS) by the histology core facility at the Washington University School
of Medicine. Assessment of epithelial growth was performed by measur-
ing the height of the epithelial layer from the basal lamina to the apical
surface using	40magnification and themicroscope’s ocularmicrometer
(45).
Transcript analysis by real-time reverse transcription-PCR (RT-
PCR). Following collection, RNA in vaginal wash fluid was stabilized by
addition of 10 volumes of RNAlater solution (Qiagen, Valencia, CA), and
samples were immediately processed or frozen at 80°C for later use.
Total RNA was isolated from vaginal wash fluid or homogenized vaginal
tissue by shaking with 0.1-mm silica spheres using Lysing Matrix B Fas-
tRNA tubes and a FastPrep high-speed reciprocating shaking device
(QBioGene, Carlsbad, CA). RNAwas further purified by use of an RNeasy
minikit (Qiagen). Genomic DNA was removed by digestion during isola-
tion (RNase-free DNase set; Qiagen) and by treatment with DNase I (am-
plification grade; Invitrogen) following spin-column purification. The in-
tegrity of the RNA was assessed by electrophoresis, and purity was
measured by determination of theA260/A280 ratio (puritywas acceptable if
it was 
1.8). Synthesis of cDNA was performed using an iScript cDNA
synthesis kit (Bio-Rad, Hercules, CA). Real-time amplification of select
genes was performed using an iCycler thermocycler (Bio-Rad) and iQ
SYBR green Supermix (Bio-Rad). The primers used are listed in Table S1
in the supplemental material. Relative transcript levels were determined
using the 2CTmethod (46). Transcript levels for recA (SPy_2116)were
used to normalize expression levels for each gene of interest, as the level of
recA transcription is stable using the indicated experimental conditions
(47). The specificity of the primers for S. pyogenes-specific cDNA was
evaluated using RNA samples prepared from estradiol-treated but non-
colonized mice; under these conditions, the primer sets either failed to
produce DNA amplification products or produced amplicons that were
distinctly different by melting point analysis (data not shown). Values
represent the means and standard errors of the means of three indepen-
dent experiments, each analyzed in duplicate (vaginal washes from six
mice used per group).
H2O2 production and sensitivity to H2O2. Production of hydrogen
peroxide (H2O2) was measured following growth in liquid C medium as
previously reported (48).Data reported are themeans and standard errors
of themeans normalized to the results for strain HSC12 in Cmedium (set
to 100%) from at least three independent measurements from separate
days. All of the experimental comparisons were performed in parallel, and
similar trends were observed with shorter periods of incubation (harvest-
ing of the medium at earlier time points in stationary phase), although
peroxide accumulationwasmaximal in our studies after overnight growth
(late stationary phase), and therefore, this point was chosen for these
experiments. For determination of the sensitivity of strains to exogenous
peroxide, 5 l of overnight growth in THY broth was inoculated into 200
l of fresh THY medium supplemented with up to 5 mM hydrogen per-
oxide (Sigma), cultured in 96-well plates sealed with plastic tape, and
incubated overnight at 37°C. The indicated peroxide concentration is the
concentration prior to inoculation and growth. The final growth density
was measured by determination of the absorbance (OD600) using a mi-
croplate reader (Infinite 200 PRO series; Tecan US, Inc., Durham, NC).
Shown are mean and standard error of the mean values; each point is
representative of 2 independent experiments, each performed in tripli-
cate.
Statistical analyses.Differences in the duration of S. pyogenes vaginal
carriage were tested for significance using a log-rank analysis of Kaplan-
Meier product limit estimates. Differences between groups for recovery of
CFU in vaginal washes and in leukocyte counts from vaginal smears over
time were tested using a repeated-measures analysis of variance. Differ-
ences in relative transcript levels, peroxide production, and sensitivity
were tested for significance with a two-tailed paired t test. For all tests, the
null hypothesis was rejected for P values of0.05. For statistical compu-
tation, the resources available in GraphPad Prism software (GraphPad
Software, Inc., San Diego, CA) or the VassarStats Site for Statistical Com-
putation by Richard Lowry (http://faculty.vassar.edu/lowry/VassarStats
.html) were used.
RESULTS
Colonization of murine vaginal mucosa by S. pyogenes is en-
hanced by pretreatment with estradiol. For many pathogens,
colonization of the murine vaginal mucosa is enhanced by pre-
treatment with estradiol and is more efficient during the estrus
phase of the estral cycle for reasons that have not been fully estab-
lished (12–15, 49). To determine if S. pyogenes vaginal carriage
responded similarly, C57BL/6J or BALB/c mice received intraper-
itoneal injections of 17-estradiol at 48 h prior to inoculation and
again on the day of inoculation (day 0). Approximately 1 	 106
CFU of S. pyogeneswas then deposited into the vaginal vault in 20
l of PBS, and colonization was assessed by determination of the
number of S. pyogenes CFU recovered from a single 50-l wash.
Individual samples were collected intermittently over a period of
34 days. In C57BL/6J mice treated with vehicle alone (sesame oil
with no estradiol), inoculation with wild-type strain HSC12 ex-
hibited a median duration of colonization of 13 days (range, 2 to
22 days; Fig. 1A). Mice treated with injections of 0.005 mg of
estradiol had amedian duration of colonization of 14 days (range,
12 to 22 days; P 0.477). However, higher doses resulted in sig-
nificantly enhanced colonization, as treatment with 0.05 or 0.5mg
of estradiol resulted in median durations of colonization of 22
days (range, 18 to up to 34 days; P 0.0207) and 32 days (range,
26 to up to 34 days; P 0.0001), respectively (Fig. 1A). Estradiol-
treatedmicemaintained a higher S. pyogenes bacterial density over
time, which for pretreatment with 0.5mg estradiol remained con-
sistently between 106 and 107 CFU recovered in washes over the
first 18 to 22 days (Fig. 1B). In contrast, for mice treated with
vehicle alone, the decline in the numbers of recoverable S. pyo-
genes CFU was significantly more rapid (Fig. 1B). Thus, coloniza-
tionwas sensitive to the amount of estradiol, with increasing doses
correlating with a concomitant increase in recovery of S. pyogenes
from washes (data not shown for 0.005 and 0.05 mg estradiol-
treated groups). However, colonization was not sensitive to a
higher inoculum, as infection by 1 	 108 CFU did not result in
significantly higher levels of carriage following day 4 (data not
shown). Colonization capacity and the numbers of recoverable
CFU were similar in response to estradiol supplementation in
BALB/c mice, suggesting that this model could potentially be ap-
plied to several mouse strains (data not shown). Remarkably, col-
onized mice were asymptomatic and demonstrated no overt signs
S. pyogenes Vaginal Mucosa Carriage Model
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of illness, including fur ruffling, lethargy, weight loss, ulcer forma-
tion, or purulent vaginal discharge. Since pretreatment with 0.5
mg estradiol followed by inoculation with 1 	 106 CFU of S.
pyogenes supported the longest carriage duration and the highest
bacterial load in the absence of any adverse effects of estradiol
supplementation, such as overgrowth of normal vaginal flora con-
taminating our selectivemedium containing streptomycin or oth-
erwise causing illness in the mice, this regimen was chosen for use
in subsequent experiments, unless otherwise stated.
Estradiol supplementation is associated with decreased in-
flammation in S. pyogenes-colonized murine vaginal tissue. Es-
tradiol is known to promote the estrus phase of themurine estrous
cycle, a period associated with proliferation and thickening of the
vaginal epithelium, production of glycogen, and a reduction in the
presence of inflammatory cells (15). To characterize the changes
elicited by the treatment regimen used here and by S. pyogenes
colonization, a histological analysis was conducted. Following
treatment with vehicle alone, the normal and healthy appearance
of the vaginal tissue of C57BL/6J mice in the absence of coloniza-
tion (Fig. 2A) changed following infection, with the presence of an
increased number of inflammatory cells, particularly at the epi-
thelial surface, as noted by day 8 postinoculation (Fig. 2B, arrow).
Preestrogenizedmice exhibited a significant thickening of the vag-
inal epithelium (Fig. 2C), with an associated significant increase in
the quantified height from the basal lamina to the apical surface
(9.3 0.9 units versus 16.6 1.7 units; P 0.001). In addition,
staining of sections from pretreated mice with the periodic acid-
Schiff (PAS) reagent, used for glycogen staining, showed an in-
creased amount of staining, suggestive of increased glycogen
deposition (data not shown). In contrast to non-estradiol-supple-
mented mice, supplemented mice did not exhibit any apparent
increase in the presence of inflammatory cells following coloniza-
tion with S. pyogenes at day 8 (compare Fig. 2C and D), and the
epithelium appeared intact and healthy.
Estradiol supplementation suppresses vaginal fluid leuko-
cyte concentration.The analysis presented above suggested that a
decreased presence of inflammatory cells correlated with the abil-
ity of estradiol to enhance S. pyogenes colonization. To examine
this in greater detail, the composition of vaginal cells in smears of
FIG 1 Estrogenization promotes S. pyogenes vaginal colonization. Groups of 5
C57BL/6J mice each were pretreated with the indicated concentrations of es-
tradiol or with sterile sesame oil only (mock). Mice received treatments at day
2 and just prior to vaginal inoculation (day 0). Mice were then challenged
with 1	 106 CFU of S. pyogenesHSC12, and the numbers of CFU were deter-
mined at the time points indicated by washing the vaginal vault with 50 l of
PBS and plating the washes on medium containing streptomycin. Data for
mice treated with 0.5 mg of estradiol and mock-treated mice are pooled from
3 independent experiments, representing a total of 15mice each; data for mice
treated with 0.005 mg and 0.05 mg of estradiol are from a single experiment,
representing 5 mice each. (A) Kaplan-Meier analysis to compare the number
of mice from each group that remained colonized. A log-rank analysis indi-
cated that treatment with 0.5 mg (P 0.001) and 0.05mg (P 0.05) estradiol
promoted a significantly longer period of colonization than mock treatment.
(B) Comparison of the number of S. pyogenes CFU recovered in vaginal
washes. Shown are the mean and standard error of the mean of the number of
CFU recovered in 50-l washes at each time point. An individual mouse was
considered colonized when any streptomycin-resistant S. pyogenes isolate was
recovered in culture at a level above the limit of detection (LOD), calculated to
be 84 CFU/ml. A repeated-measures analysis of variance test comparing the
number of CFU recovered over the time points assayed indicated that the
group treated with 0.5 mg estradiol exhibited significantly greater numbers of
CFU recovered than the mock-treated group (P 0.001).
FIG 2 Estradiol treatment promotes vaginal mucosal thickening and de-
creased inflammation in S. pyogenes-colonized vaginal tissue. Estradiol-treated
(0.5 mg) and mock-treated mice were left uncolonized or were colonized by
vaginal inoculation of 1 	 106 CFU of S. pyogenes HSC12. Shown are cross
sections of vaginal walls from organs harvested at 8 days postinoculation that
were stained with hematoxylin-eosin and imaged. Anatomy landmarks are the
vaginal lumen (VL), epithelium (E), and lamina propria (LP). (A) Mock
treated, uncolonized; (B) mock treated, colonized; (C) estradiol treated,
uncolonized; (D) estradiol treated, colonized. Note the thickening of the
epithelium in panels C and D following estradiol treatment. For colonized
tissue, note the decreased numbers of leukocytes (arrow in panel B) in the
epithelium of estradiol-treated (D) versus non-estradiol-treated (B) mice.
Magnifications, 	40.
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vaginal fluid was examined since this predictably fluctuates
throughout the estrous cycle and can be used to determine the
stages of individual mice and monitor mucosal inflammation
(40). As expected for mice cycling with natural levels of endoge-
nous hormones, C57BL/6J mice injected with sterile sesame oil
alone and inoculatedwith PBS exhibited only a fluctuating density
of leukocytes that peaked every 4 to 6 days (Fig. 3A). In contrast,
estradiol-treatedmice had a significant blunting of leukocyte den-
sity that appearedwithin 24 h and persisted for about 10 to 14 days
(Fig. 3A). When estradiol-treated mice were colonized with 106
CFUHSC12, there was not a statistically significant increase in the
vaginal fluid leukocyte presence compared to that for estradiol-
treated but uncolonizedmice (compare Fig. 3B to A), replicating a
relatively asymptomatic carriage observed in women of reproduc-
tive age. Despite estradiol supplementation, the vaginal mucosa
was still capable of mounting an inflammatory response, as a
higher HSC12 inoculum (1 	 108 CFU) elicited a significant in-
crease in vaginal fluid leukocyte density (Fig. 3B). Higher leuko-
cyte densities developed at the later time points and were tempo-
rally associatedwith the beginning of a decline in viable S. pyogenes
HSC12 recovered from vaginal washes (Fig. 3B; compare to
Fig. 1B). As mentioned above, there was no significant difference
in S. pyogenes colonization frequency and the number of CFU
recovered from vaginal washes between C57BL/6J and BALB/c
mouse strains; however, estradiol-treated BALB/c mice showed
significantly elevated numbers of leukocytes in vaginal washes
compared to C57BL/6Jmice (Fig. 3B). Therefore, leukocyte influx
into vaginal fluid did not correlate exactly with the clearance of S.
pyogenes from vaginal carriage, as colonization persisted through
periods of high vaginal fluid leukocyte density and eventually de-
clined over time. Monitoring of leukocyte influx following colo-
nizationmay better serve as amarker of inflammation rather than
an indicator of S. pyogenes clearance.
Estradiol treatment promotes colonization of multiple S.
pyogenes strains. In order to assess the compatibility of the pre-
estrogenized murine vaginal carriage model with different S. pyo-
genes strains, five diverse S. pyogenes strains with distinct M types
were tested, including HSC12 (M14), MEW29 (M1), JRS4 (M6),
MEW123 (M28), and MEW132 (M49) (listed in Table 1) (38, 43,
50). In particular, note thatMEW123 is anM28 isolate, andmem-
bers of this group are overrepresented in cases of human female
urogenital tract infection, puerperal sepsis, and neonatal infec-
tions (25–27). All strains were able to establish long-term asymp-
tomatic colonization in estradiol-pretreated mice (Fig. 4). There
was no significant difference in the kinetics of clearance between
MEW29, MEW123, and HSC12, and all three strains had similar
median durations of colonization (range, 6 to 34 days) over the
34-day period of observation. However, despite similar median
durations of colonization, analysis of clearance kinetics revealed
that carriage by JRS4 and MEW132 was significantly prolonged
compared to that by HSC12, MEW29, and MEW123 (Fig. 4).
When colonization densities were compared, the numbers of CFU
of HSC12, MEW123, and MEW132 recovered in vaginal washes
were consistently and significantly higher over the first 22 days
than the numbers of CFUof either JRS4 orMEW29 (Fig. 4). Thus,
the preestrogenized murine vaginal carriage model is robust in its
ability to support colonization by multiple diverse strains, al-
though the different strains produce varied patterns of coloniza-
tion.
S. pyogenes CcpA promotes mucosal carriage. Given the
proximity of glycogen and other complex carbohydrate substrates
in vaginal epithelial tissue, the role of CcpA, a central regulator of
gene expression in response to carbohydrates, was examined.
Since strain HSC12 consistently showed stable high-level coloni-
zation over a period of 3 to 4 weeks, this strain was chosen for this
analysis and is referred to as thewild type (WT).When amutant of
HSC12 containing an in-frame deletion of ccpA (SPy_0514) was
inoculated into preestrogenizedC57BL/6Jmice, it was found to be
significantly attenuated for carriage at the vaginal mucosa, having
amedian duration of 8 days (range, 2 to 14 days) versus the 30 days
(range, 26 to up to 34 days) obtained for the WT strain (Fig. 5A).
Restoration of the wild-type ccpA locus in themutant background
also restored the ability of the resultingCcpAr strain (MEW106) to
colonize at levels equivalent to those for the wild-type strain with
a median duration of up to 34 days (range, 26 to 34 days; Fig. 5A),
and the numbers of recoverable CFU from vaginal washes were
not significantly different from those for the wild-type strain (Fig.
5B). Determination of the numbers of viable CFU showed a rapid
decline in the recovery of the CcpA strain from vaginal washes
compared to the levels of recovery of the CcpAr and wild-type
FIG 3 Leukocyte concentration in vaginal wash specimens. Vaginal washes
from estradiol-treated (0.5 mg) and mock-treated mice were collected at the
indicated time points following challenge with S. pyogenes HSC12. Samples
were stained with a modified Wright-Giemsa stain for determination of the
number of leukocytes by microscopic examination. Leukocyte concentrations
are expressed as the percentage of leukocytes relative to the total number of
cells recovered. Each symbol represents the mean and standard error of the
meanderived from6mice at each timepoint.Differences betweenmean values
over time were tested for significance using a repeated-measures analysis of
variance. (A) C57BL/6J mice were treated as indicated, and vaginal washes
were analyzed for leukocyte influx. Leukocyte concentrations were signifi-
cantly lower in estradiol-treated mice over the period of observation (P 
0.01). (B) BALB/c orC57BL/6Jmicewere estradiol treated and challengedwith
S. pyogenes HSC12 at the inoculum densities indicated. Over the period of
observation, a dose of 1	108 CFU and colonization of BALB/cmicewere both
associated with significantly higher leukocyte concentrations relative to those
in C57BL/6J mice challenged with 1	 106 CFU (P 0.01).
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HSC12 strains (Fig. 5B). Analysis of homogenates of vaginal tissue
revealed that no CFU were recovered from mice that had cleared
the CcpA strain, as assessed by recovery in vaginal washes, show-
ing that the mutant did not continue to persist in an intracellular
reservoir (data not shown). A histological analysis showed that
infection by the CcpA strain did not produce inflammation and
there was no significant influx of leukocytes into the vaginal fluid
during the clearance phase of the infection (data not shown).
Taken together, these results demonstrate that CcpA plays a crit-
ical role in promoting mucosal colonization.
Dysregulation of gene expression in the CcpAmutant con-
tributes to impairedmucosal carriage. In order to investigate the
molecular basis for the attenuation of theCcpA strain, gene tran-
script levels were analyzed following recovery of streptococcal
RNA from vaginal wash specimens. The specific transcripts mea-
sured (Table 2) were chosen on the basis of regulation by CcpA
both during in vitro growth and during infection of murine sub-
cutaneous tissue (33, 34) and were analyzed by real-time RT-PCR
at 48 h and 96 h postinoculation. Surprisingly, relatively few tran-
scripts were found to differ in expression between the CcpA
strain and the WT strain in this model system (Table 2). Excep-
tions were a decreased expression of speB, which encodes a
cysteine protease, and a significantly enhanced expression of lctO,
which encodes lactate oxidase, a peroxide-producing enzyme (Ta-
ble 2). The latter observation is consistent with the findings of
prior studies that show that CcpA binds to a catabolite-responsive
element site with the lctO promoter and functions as a repressor of
lctO expression (33). Furthermore, derepression of lctO is associ-
ated with self-intoxication caused by the overproduction of H2O2
in the presence of oxygen (33). To determine if excess LctO ex-
pression was limiting vaginal mucosa carriage, a previously char-
acterized in-frame deletionmutation (33)was introduced into the
WT and CcpA strains. As expected, inactivation of ccpA in the
HSC12 background was associated with a significant increase in
H2O2 production that was insensitive to repression by glucose
(Fig. 6A). Interestingly, the CcpA mutant was found to have
increased susceptibility to H2O2, as revealed by a lower growth
yield in the presence of 2mMH2O2 supplemented into the growth
medium (Fig. 6B); we suspect that a small amount of H2O2 pro-
duced in the absence of LctO repression by CcpA in this system
added to the 2 mM H2O2 supplemented in the medium and ex-
ceeded a threshold level where the CcpA strain was differentially
inhibited. Also as expected, the inactivation of lctO by itself or in
the CcpA strain background (a double CcpA LctO mutant
strain) abrogated both peroxide production in aerated cultures
(Fig. 6A) and the CcpA strain’s increased sensitivity to 2 mM
H2O2 (Fig. 6B).When analyzed in preestrogenizedmice, the dou-
ble CcpA LctOmutant strain was not attenuated compared to
the defectiveCcpA strain, and its phenotypewas essentially iden-
tical to that of the WT strain in both the median duration of
carriage (Fig. 5A) and bacterial burden (Fig. 5B). The fact that the
LctO strain also did not demonstrate any attenuation of carriage
(Fig. 7A and B) shows that the suppressive effect of this mutation
was specific to the CcpA background and was likely due to its
FIG 4 Several strains of S. pyogenes are capable of colonizing the murine vagina. Estradiol-treated mice (0.5 mg) were vaginally challenged with 1	 106 CFU of
S. pyogenes strains HSC12, JRS4, MEW29, MEW123, andMEW132. The left axis of each panel shows the results of a Kaplan-Meier analysis of the percentage of
mice that remained colonized at the indicated time points. The right axis shows the mean number of CFU recovered in vaginal washes, where each symbol
represents themean and standard error of themean derived from 14 (HSC12), 18 (JRS4), 19 (MEW29), 10 (MEW123), and 10 (MEW132)mice challenged with
the indicated strains. A log-rank analysis indicated that strains HSC12, MEW29, and MEW123 had significantly shorter durations of colonization than strain
JRS4 orMEW132 (P 0.01). A repeated-measures analysis indicated that strainHSC12 had a significantly higher number of CFU over the period of observation
than strains JRS4 (P 0.001), MEW29 (P 0.001), and MEW132 (P 0.01).
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ability to alleviate overexpression of LctO. Thus, these data dem-
onstrate that CcpA makes a critical contribution to mucosal car-
riage by its ability to downregulate a gene whose overexpression
decreases fitness in the mucosal environment.
DISCUSSION
Investigation of factors critical to mucosal colonization and car-
riage in S. pyogenes has been hampered by the fact that it is a
human-restricted pathogen with no known animal or environ-
mental reservoir. Previous animal models for S. pyogenes have
suffered from the fact that the number of strains which can func-
tion in those models and/or reproduce the disease phenotype was
limited (10, 51, 53, 54). This work presents a novel animal model
of S. pyogenes mucosal colonization and carriage which will po-
tentially advance the field of streptococcal host-pathogen interac-
tions at the mucosal surface. Importantly, the preestrogenized
murine vaginal colonization model is capable of supporting at
least five diverse S. pyogenes strains, including the M14 HSC12,
M6 JRS4, M1 SF370, and M49 NZ131 strains and an M28 isolate,
MEW123, and this will facilitate investigation into factors distin-
guishing carriage ability between different strains. There are likely
multiple differences between these strains in terms of expression
of various adhesins, exotoxins, and other potential virulence fac-
tors that could account for their variable phenotypes in vaginal
mucosa carriage. As just one example, strains HSC12 and SF370
display oxygen-induced expression of the fibronectin-binding ad-
hesin protein F (prtF) and do not express this protein under an-
aerobic conditions; in contrast, JRS4 has a mutation in the regu-
latory gene rofA which permits constitutive expression of protein
F, even anaerobically (39).
Another advantage of using amurine vaginal model to study S.
pyogenes colonization was the relative ease of access to the tissues
to monitor the mucosal immune response. In this model, an in-
flux of vaginal leukocytes was found to be a marker of inflamma-
tion, with higher leukocyte percentages being noted in vaginal
washes from BALB/c mice than those from C57BL/6J mice. A
previous study (55) also reported a significantly higher vaginal
fluid leukocyte response from BALB/c mice than C57BL/6J mice,
when bothwere similarly colonized withN. gonorrhoeae, support-
ing a difference between the two mouse strains in the innate im-
mune response that may be common to several mucosal patho-
gens. Therefore, the vaginal carriage model may be useful in
investigating other bacterial factors that interact with the innate
response to mucosal pathogens, and using BALB/c mice as the
host in this model may help highlight factors affecting inflamma-
tion. Furthermore, this model may help explain the inverse rela-
tionship between estrogen availability and symptomatic S. pyo-
genes vaginal disease in humans. For unclear reasons,
vulvovaginitis tends to be more common in prepubertal girls,
postmenopausal women, and women with other hypoestrogen
conditions (20, 22–24). In our model, estradiol supplementation
was associatedwith asymptomatic carriage, which seems tomimic
the situation in women of reproductive age vaginally colonized
with S. pyogenes. Estradiol supplementation is known to promote
the estrus phase of themurine estrous cycle, a time associatedwith
vaginal epithelium proliferation and thickening, production of
glycogen, and a minimal presence of inflammatory cells (15). Es-
TABLE 2 Only a subset of CcpA-regulated genes is dysregulated in the
CcpAmutant during vaginal carriage
Transcriptb
Relative transcript expressiona
48 h P value 96 h P value
speB 0.07 0.06 0.010 0.48 0.35 0.116
lctO 5.76 2.18 0.001 4.58 1.09 0.053
hasA 0.94 0.10 0.545 0.40 0.05 0.203
sagA 0.62 0.12 0.140 0.72 0.24 0.303
malM 1.04 0.27 0.873 1.13 0.53 0.772
cfa 1.59 0.72 0.122 0.43 0.30 0.077
ackA 0.85 0.22 0.200 0.77 0.70 0.463
arcA 1.82 1.70 0.506 2.51 3.04 0.267
a Relative transcript expression is expressed as expression for the CcpA
strain/expression for HSC12, with the 2CT value normalized using the transcript
level of recA (46). Values represent means standard errors of the means of three
independent experiments, each analyzed in duplicate. Samples are from 48 h and 96 h
postinoculation. For each experimental group (WT and CcpA) vaginal washes from
six mice were included in the analysis.
b The recA (SPy_2116), speB (SPy_2039), lctO (SPy_0414), hasA (SPy_2200), sagA
(SPy_0738),malM (SPy_1292), cfa (SPy_1273), ackA (SPy_0109), and arcA (SPy_1543)
transcripts were analyzed on the basis of previous work showing that these genes are
CcpA regulated (32, 33, 34).
FIG 5 Deletion of CcpA limits the duration of mucosal carriage. Estrogen-
treated (0.5mg)C57BL/6Jmicewere vaginally challengedwith 1	 106 CFUof
S. pyogenes strains HSC12 (WT) and MEW41 (CcpA) and revertant strain
MEW106 (CcpAr). Vaginal washes were collected at the time points indicated
and processed for determination of the number of CFU. (A) Kaplan-Meier
analysis of the percentage of mice that remained colonized. Log-rank analysis
indicated that the CcpAmutant was significantly attenuated compared to the
WT and CcpAr strains (P 0.001). (B) Numbers of CFU recovered in vaginal
washes. Each symbol represents the mean and standard error of the mean
derived from 20 (WT), 19 (CcpA), and 5 (CcpAr) mice challenged with the
indicated strains. LOD, limit of detection, calculated to be 84 CFU/ml. A re-
peated-measures analysis indicated that the CcpA mutant was significantly
attenuated compared to the WT and CcpAr strains (P 0.001).
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tradiol exerts activity through two distinct estrogen receptors (es-
trogen receptor  [ER] and ER) that populate different tissues
and cell lines (56). Estrogen receptor has previously been shown
to have anti-inflammatory activity with repression of multiple cy-
tokines in immune cells, whereas ER is more associated with
anabolic activity in the female mammary gland and reproductive
tract (57). Which receptor and which pathway are more impor-
tant for producing asymptomatic S. pyogenes carriage are un-
known, but the murine vaginal carriage model could provide
valuable insight into estradiol and its link to carriage and inflam-
mation.
The utility of the murine vaginal model in identifying strepto-
coccal factors contributing to carriage was demonstrated in this
work by demonstrating the critical role of the transcriptional reg-
ulator CcpA. Previous investigations have identified virulence de-
fects in CcpA strains of several species of Staphylococcus, Strep-
tococcus, and Clostridium, among others (32, 33, 52, 58–62). The
abundance of data linking CcpA’s regulatory activity to virulence
confirms the importance of CcpA, among other global transcrip-
tional regulators, in a central role for disease pathogenesis. The
results of the present study add to the growing body of knowledge
linking CcpA and virulence through mucosal colonization ability
and demonstrate that dysregulated expression of LctO, a CcpA-
regulatedmetabolic enzyme, is responsible for limiting survival in
a CcpA strain. Importantly, this study illustrates that dysregula-
tion of transcriptional expression can negatively impact an organ-
ism’s ability tomaintain colonization, an observation that is likely
broadly applicable to many mucosal pathogens.
Carbon catabolite repression by CcpA is a complex process
that allows a pathogen to regulate metabolism and virulence fac-
tor expression in response to changing environmental conditions
following infection (such as the depletion of available carbohy-
FIG 6 Hydrogen peroxide production and sensitivity of CcpAmutants. (A)
H2O2 production following overnight culture in aerated C medium with ()
and without () supplemented glucose (5 mM). H2O2 levels are shown rela-
tive to those in the WT strain. Data presented are the means and standard
errors of the means derived from a minimum of 3 independent experiments.
(B) H2O2 sensitivity. Strains were cultured in THY medium supplemented
with the indicated concentrations of H2O2 prior to inoculation. Culture den-
sity was assessed after overnight static culture by determination of the OD600.
Data represent the means and standard errors of the means derived from 2
independent experiments, each performed in triplicate. The strains tested are
HSC12 (WT),MEW41 (CcpA),MEW16 (LctO),MEW47 (CcpA LctO),
andMEW106 (CcpAr). Comparisons betweenHSC12 andmutant within each
H2O2 concentration utilized a two-tailed, paired t test: *,P 0.05; **,P 0.01;
***, P 0.001.
FIG 7 Deletion of LctO rescues a CcpA strain. Estrogen-treated (0.5 mg)
C57BL/6J mice were vaginally challenged with 1 	 106 CFU of S. pyogenes
strains HSC12 (WT) and MEW16 (LctO) and the double mutant MEW47
(CcpA LctO). Vaginal washes were collected at the time points indicated
and processed for determination of the numbers of CFU. (A) Kaplan-Meier
analysis of the percentage ofmice that remained colonized. A log-rank analysis
indicated that both the LctO singlemutant andCcpALctOdoublemutant
exhibited significantly longer durations of carriage than theWT (P 0.0001).
(B) Numbers of CFU recovered in vaginal washes. Each symbol represents the
mean and standard error of the mean derived from 20 (WT), 17 (LctO), and
18 (CcpA LctO) mice challenged with the indicated strain. LOD, limit of
detection, calculated to be 84 CFU/ml. A repeated-measures analysis compar-
ing the numbers of CFU recovered over the entire 34-day time frame of the
experiment between theWT, the LctOmutant, and theCcpALctOdouble
mutants did notmeet statistical significance. A subset repeated-measures anal-
ysis comparing the numbers of CFU recovered over days 22 through 34 of the
experiment between the three groups showed that both the LctOmutant and
the CcpA LctO double mutant exhibited significantly higher numbers of
CFU recovered from vaginal washes than the WT (P 0.0001).
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drates) or upon encountering a new environment or stage in the
infectious process. In support of this, S. pyogenes CcpA strains
recovered from the relatively confined environment of themurine
skin ulcer model showed that dysregulation was not a static all-on
or all-off process, but even among genes that were strongly regu-
lated by CcpA in vitro, there were rather dynamic fluctuations in
the magnitude of differences between gene expression patterns
between wild-type and CcpA strains (34). Some of these fluctu-
ationsmay have been due to changing carbohydrate availability in
the ulcer tissue bed; others may be due to the influence of addi-
tional factors, including LacD.1, which function as coregulatory
proteins along with CcpA for some gene transcripts, including the
cysteine protease SpeB (33, 34).
The present study identifies an increase in the transcription of
LctO from vaginal washes colonized by CcpA strains; however,
beyond LctO there were relatively few differences in transcript
expression identified from vaginal washes of mice colonized with
the CcpA strain and mice colonized with the HSC12 parent
strain at the time points examined (Table 2). This could be due to
several reasons. S. pyogenes organisms colonizing the murine vag-
inal epithelium could be relatively metabolically inactive with a
low level of transcriptional activity that could make finding com-
parative differences difficult. Alternatively, the little to no differ-
ence in transcript expression between CcpA strains and the
HSC12 parent strain could suggest that available carbohydrate
levels in the murine vaginal mucosa are not sufficient to signal
CcpA-mediated regulation to a significant degree to promote dif-
ferences. It has previously been determined that estradiol-treated
murine and human vaginal secretions both have glucose concen-
trations of 3 to 4 mM, which calculates to about 0.072% (wt/vol)
(19). Prior experiments by our group showed a significant reduc-
tion in lctO transcription in vitro with 0.1% glucose in C me-
dium (33); thus, it is possible that in themurine vaginal model the
glucose concentrations were too low to show significant differ-
ences for many genes normally regulated by CcpA. S. pyogenes
HSC12 can utilize a variety of carbohydrate sources, most of
which are ultimately converted to glycolytic intermediates which
activate CcpA-mediated repression of LctO. Vaginal secretions
contain monosaccharides, including glucose, mannose, and glu-
cosamine, in addition to oligosaccharides, including maltose,
maltotriose, andmaltotetraose (63, 64). Carbon catabolite repres-
sion in strain HSC12 can be induced by glucose, maltose, malto-
triose, pullulan, galactose, and mannose (data not shown); strain
HSC12 cannot directly utilize glycogen or lactose, although other
bacterial species present in the vaginal flora may degrade these
sugars into forms that S. pyogenes strain HSC12 can utilize for
carbon catabolite repression. Another possibility is that in themu-
rine vaginal environment, there are perhaps additional coregula-
tory proteins (LacD.1, among other possibilities) that could be
acting to help coordinate gene expression in the absence of input
fromCcpA. In our experiments, however, even in a CcpA strain,
dysregulation of gene expression on a global scale did not suffi-
ciently explain the attenuation in carriage more so than dysregu-
lation of a single gene, as observed when inactivation of LctO in
the CcpA background prolonged carriage of the double mutant
strain.
When in the presence of glycolytic intermediates, CcpA binds
to the lctO promoter within a catabolite-responsive element se-
quence located upstream of the lctO ATG translation start site,
blocking lctO transcription. In the CcpA strain, LctO transcrip-
tion is largely unchecked, producing abundant amounts of perox-
ide that accumulate to lethal concentrations (33). Inactivation of
LctO in the CcpA strain prevented hydrogen peroxide produc-
tion, and this resulted in a prolonged in vivo duration of carriage
of the CcpA LctO strain. In S. pyogenes, lactate oxidase is the
principal enzyme producing significant levels of hydrogen perox-
ide; the enzyme NADH oxidase also contributes a small and rela-
tively insignificant amount of detectable peroxide (65); this fact
may explain why H2O2 production in the LctO
 and CcpA
LctO strains was low but not undetectable (Fig. 6A). Among
both clinical isolates and lab-generated mutants, inactivation of
LctO activity and reduced hydrogen peroxide production have
previously been demonstrated to prolong stationary-phase sur-
vival under aerobic conditions (33, 65, 66). It was surprising to
find such a strong phenotype related to peroxide production in the
murine vaginal compartment, as traditional thought is that the
vaginal environment is of relatively low oxygen tension (67).
However, in humans, vaginal lactobacillus species producing hy-
drogen peroxide are thought to be associated with vaginal health
and a reduced risk of acquiring disease, such as bacterial vaginitis
(68–70). By this, the vaginal compartment presumably has suffi-
cient available oxygen for lactobacillus and, likewise, S. pyogenes to
have the capacity to produce peroxide. Alternatively, theremay be
differences in the oxygen tension present in the murine vaginal
environment and that present in the human vaginal environment.
Oxygenmayhave been further introduced into themurine vaginal
compartment in ourmodel via repeat vaginal specimen collection
for culture; mechanical insertion of contraceptive diaphragms or
tampons has previously been shown to transiently increase the
vaginal oxygen content in humans (67, 71).
The present study is not the first to find that CcpA strains are
attenuated inmucosal colonization and carriage. CcpA strains of
Streptococcus pneumoniae were previously demonstrated to be at-
tenuated for carriage in the murine nasopharynx (62), just as S.
pyogenes was attenuated for carriage in the murine oropharynx
(32). Neither of these prior studies identified specific defects that
could complement the CcpA strain phenotype like the double
ccpA lctO mutations were capable of doing in this study. In S.
pneumoniae, H2O2 production under aerobic conditions ismostly
due to the activity of pyruvate oxidase (SpxB); under glucose lim-
itation, the pneumococcal LctO also shows peroxide-generating
activity. In S. pneumoniae, LctO was also found to be upregulated
in CcpA strains; however, SpxB was not influenced by ccpA de-
letion, as determined by microarray analysis (62, 72). Pneumo-
coccal stains producing peroxide have competitive advantages
within mixed bacterial populations, presumably by inhibiting the
growth of peroxide-susceptible species (73, 74). However, S.
pneumoniae SpxB mutants were found to be defective in animal
models of nasopharyngeal colonization, pneumonia, and sepsis,
although factors in addition to peroxide generation alone may
have contributed to this phenotype (74–77). In our model of S.
pyogenes vaginal colonization, we noted no significant defect in
carriage of strainswith amutation of lctO. Altogether, these results
suggest that regulated hydrogen peroxide generation by several
streptococcal species is critical for mucosal colonization and vir-
ulence.
Asymptomatic mucosal carriage with S. pyogenes is a concept
that remains poorly understood, in terms of both the basic science
underlying the microbiology and immunology occurring at the
mucosal surface and the clinical science on how to manage pa-
S. pyogenes Vaginal Mucosa Carriage Model




arch 31, 2014 by W







tients who are carriers of group A streptococcus. As shown here,
the vaginal colonization model is effective for investigating traits
critical for S. pyogenesmucosal carriage. This model should prove
beneficial in future investigations of S. pyogenes mucosal coloni-
zation and carriage and investigation of the role of innate and
adaptive host immune properties in response to carriage, an un-
derstanding of which will be key to the development of anti-S.
pyogenes vaccines effective at the mucosal surface.
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